Clinical Trials in Texas

Showing 2161-2180 of 7,265 trials

Driving Rehabilitation and Innovation for Evaluating Risk in Post-Intensive Care Unit Survivors

NCT05999903

Older adults are at risk for ICU-acquired cognitive decline discernible from clinical, biological, and imaging- related changes in the brain following delirium and critical illness. Our Driving Rehabilitation and Innovation for Evaluating Risk in Post Intensive Care Unit Survivors (DRIVE-PICS) application seeks to implement in-vehicle kinematic driving data with neurocognitive assessments for essential formative work to develop data-based insights into driving behaviors. DRIVE-PICS is designed to contribute to a critical gap in health promotion to develop an evidence-based, in-vehicle driving assessment system to provide actionable driving safety data and rehabilitation strategies tailored to older ICU survivors, the participants' care partners, and clinicians.

DeliriumCritical IllnessDrive

Baylor Research Institute24 participantsStarted Sep 2023

Temple, Texas, United States

COMPLETEDNA38 miles

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

NCT05714059

The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.

Type 1 Diabetes

Medtronic Diabetes250 participantsStarted Feb 2023

Little Rock, Arkansas, United States • Palo Alto, California, United States • San Francisco, California, United States +20 more locations

Driving Rehabilitation and Innovation for Evaluating Risk in Post-Intensive Care Unit Survivors

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Find Trials by Condition in Texas

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

ATHN 7: Hemophilia Natural History Study

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Different Doses of Naronapride Vs. Placebo in Gastroparesis

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Artoss Prospective Spine Registry Outcomes

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007